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Background 
The apolipoprotein E (APOE) gene has three alleles ε2, ε3 
and ε4. APOE ε4 increases the risk of cardiovascular 
disease (CVD) and Alzheimer’s disease (AD) (Minihane et 
al., 2013). Also genetic variations of brain derived 
neurotrophic factor (BDNF) have a potential role in AD 
(Adamczuk et al., 2013). Healthy diets and lifestyle can 
lower risk factors for CVD and AD and lifestyle diseases in 
general, and thus are safe as an intervention. 
This study is part of the project ”Effects of ApoE4 
genotype information and intervention intensity on the 
fulfillment of lifestyle changes and sensory preferences” 
(APOE4mot). The project is a follow-up to a pilot study, 
TERVAS, in which the personal genetic information based 
on APOE had positive effects on cardiovascular risk 
markers such as improvement in triglyceride values 
(Hietaranta-Luoma et al., 2015). 
Study design 
211 participants were recruited of which 12 were excluded 
from the study in the beginning. Alanine aminotransferase, 
alkaline phosphatase, haptoglobin and thyroid stimulating 
hormone, which are biomarkers for liver and thyroid gland 
functions, were used as exclusion factors. 
The APOE genotype frequencies among the 211 
participants were following: 1 (0.5 %) ε2/ε2, 19 (9.0 %) 
ε2/ε3, 4 (1.9 %) ε2/ε4, 115 (54.5 %) ε3/ε3, 64 (30.3 %) 
ε3/ε4 and 8 (3.8 %) ε4/ε4. To study long-term effects of 
APOE genotype information, 70 participants were selected 
to the follow-up group from the pilot study TERVAS. 
APOE and BDNF genotypes and different biomarkers 
were analysed from blood (Scheme 1). Analysed 
biomarkers reflect the possible effects of genotype and are 
associated with healthy lifestyle (nutrition, physical 
activity). Other analysed biomarkers were blood count 
(leukocytes, red blood cell indices, haemoglobin, 
thrombocytes), creatinine, hs-CRP and lipid peroxidation. 
Also the amounts of APOE and BDNF proteins were 
analysed to study the effects of genotype and lifestyle 
changes on the protein production. 
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Scheme 1. Study design of the APOE4mot project related to the clinical and nutritional 
biomarkers (excluding follow-up participants from a pilot study TERVAS). 
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Objectives 
The aim is to study the effect of motivation and achieved 
lifestyle changes on clinical and nutritional biomarkers of 
study participants receiving only health information 
(control group) or health intervention and APOE ε4 risk 
status information (intervention group). Motivation, 
attitudes and preferences will be studied by lifestyle 
questionnaires and risk factors of CVD and AD (diet, 
alcohol, physical activity and health and taste) and food 
diaries depicting the starting point before the intervention 
and changes in lifestyle and food habits during and after 
the intervention. The diet questionnaires are translated to 
healthy eating index. 
The self-reported changes are verified by analysing 
clinical markers of lipid metabolism, general phenotype 
markers and profiles of nutritional markers in blood. 
Correlations between healthy eating index and plasma 
nutritional biomarkers will be calculated. 
The calculation and interpretation of the results are under 
process. 
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